John Dichiara insider trades: Regen Biologics (RGBO) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 16, 2009 | RGBO | ↑ Buy | 2,814 | $3.50 | $10K | by Ariana Dichiara | Jan 21, 2009 (5d) |
| Jan 16, 2009 | RGBO | ↑ Buy | 2,814 | $3.50 | $10K | by Michael Dichiara | Jan 21, 2009 (5d) |
| Nov 30, 2006 | RGBI | ↑ Buy | 10,000 | $0.37 | $4K | Direct | Dec 4, 2006 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About John Dichiara's insider trades
John Dichiara is Sr. Vice President at Regen Biologics (RGBO). Since Nov 30, 2006, John has reported 3 open-market purchases worth $23K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (5 filings), grants and awards (4 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RGBO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.